ParkinsonCanadaV1, PascalFrancis, Curation, bibRecord, 000219

In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy

Identifieur interne : 000219 ( PascalFrancis/Curation ); précédent : 000218; suivant : 000220

In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy

Auteurs : Hitoshi Shinotoh [Japon] ; Hiroki Namba [Japon] ; Mika Yamaguchi [Japon] ; Kiyoshi Fukushi [Japon] ; Shin-Ichiro Nagatsuka [Japon] ; Masaomi Iyo [Japon] ; Masato Asahina [Japon] ; Takamichi Hattori [Japon] ; Shuji Tanada [Japon] ; Toshiaki Irie [Japon]

Source :

Advances in neurology [ 0091-3952 ] ; 2001.

RBID : Pascal:03-0237949

Descripteurs français

Pascal (Inist)
- Cartographie, Parkinson maladie, In vivo, Voie cholinergique, Homme.
Wicri :
- topic : Cartographie, Homme.

English descriptors

KwdEn :
- Cartography, Cholinergic pathway, Human, In vivo, Parkinson disease.

A01	`01`	`1`		`@0 0091-3952`
A02	`01`			`@0 ADNRA3`
A03		`1`		`@0 Adv. neurol.`
A05				`@2 86`
A08	`01`	`1`	`ENG`	`@1 In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy`
A09	`01`	`1`	`ENG`	`@1 Parkinson's disease`
A11	`01`	`1`		`@1 SHINOTOH (Hitoshi)`
A11	`02`	`1`		`@1 NAMBA (Hiroki)`
A11	`03`	`1`		`@1 YAMAGUCHI (Mika)`
A11	`04`	`1`		`@1 FUKUSHI (Kiyoshi)`
A11	`05`	`1`		`@1 NAGATSUKA (Shin-Ichiro)`
A11	`06`	`1`		`@1 IYO (Masaomi)`
A11	`07`	`1`		`@1 ASAHINA (Masato)`
A11	`08`	`1`		`@1 HATTORI (Takamichi)`
A11	`09`	`1`		`@1 TANADA (Shuji)`
A11	`10`	`1`		`@1 IRIE (Toshiaki)`
A12	`01`	`1`		`@1 CALNE (Donald) @9 ed.`
A12	`02`	`1`		`@1 CALNE (Susan M.) @9 ed.`
A14	`01`			`@1 Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku @2 Chiba-shi, Chiba 263-8555 @3 JPN @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 6 aut. @Z 9 aut. @Z 10 aut.`
A14	`02`			`@1 ADME/TOX Research Institute, Daiichi Pure Chemicals Co., Tokai-mura @2 Naka-gun, Ibaraki 319-1182 @3 JPN @Z 5 aut.`
A14	`03`			`@1 Department of Neurology, Chiba University School of Medicine, Chuo-ku @2 Chiba-shi, Chiba 260-8670 @3 JPN @Z 7 aut. @Z 8 aut.`
A15	`01`			`@1 Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon @2 Vancouver, British Columbia @3 CAN @Z 1 aut. @Z 2 aut.`
A18	`01`	`1`		`@1 World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders" @3 INC @9 patr.`
A18	`02`	`1`		`@1 Pacific Parkinsons Research Institute @3 CAN @9 patr.`
A20				`@1 249-255`
A21				`@1 2001`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 15741 @5 354000109446770250`
A44				`@0 0000 @1 © 2003 INIST-CNRS. All rights reserved.`
A45				`@0 20 ref.`
A47	`01`	`1`		`@0 03-0237949`
A60				`@1 P @2 C`
A61				`@0 A`
A64	`01`	`1`		`@0 Advances in neurology`
A66	`01`			`@0 USA`
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Cartographie @5 02`
C03	`01`	`X`	`ENG`	`@0 Cartography @5 02`
C03	`01`	`X`	`SPA`	`@0 Cartografía @5 02`
C03	`02`	`X`	`FRE`	`@0 Parkinson maladie @5 04`
C03	`02`	`X`	`ENG`	`@0 Parkinson disease @5 04`
C03	`02`	`X`	`SPA`	`@0 Parkinson enfermedad @5 04`
C03	`03`	`X`	`FRE`	`@0 In vivo @5 07`
C03	`03`	`X`	`ENG`	`@0 In vivo @5 07`
C03	`03`	`X`	`SPA`	`@0 In vivo @5 07`
C03	`04`	`X`	`FRE`	`@0 Voie cholinergique @5 10`
C03	`04`	`X`	`ENG`	`@0 Cholinergic pathway @5 10`
C03	`04`	`X`	`SPA`	`@0 Vía colinérgica @5 10`
C03	`05`	`X`	`FRE`	`@0 Homme @5 20`
C03	`05`	`X`	`ENG`	`@0 Human @5 20`
C03	`05`	`X`	`SPA`	`@0 Hombre @5 20`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Système nerveux pathologie @5 41`
C07	`05`	`X`	`ENG`	`@0 Nervous system diseases @5 41`
C07	`05`	`X`	`SPA`	`@0 Sistema nervioso patología @5 41`
N21				`@1 146`
N82				`@1 PSI`

A30	`01`	`1`	`ENG`	`@1 Parkinson's Disease. International Congress @3 Vancouver CAN @4 1999-07-25`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000B04

Links to Exploration step

Pascal:03-0237949

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy</title>
<author><name sortKey="Shinotoh, Hitoshi" sort="Shinotoh, Hitoshi" uniqKey="Shinotoh H" first="Hitoshi" last="Shinotoh">Hitoshi Shinotoh</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Namba, Hiroki" sort="Namba, Hiroki" uniqKey="Namba H" first="Hiroki" last="Namba">Hiroki Namba</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Yamaguchi, Mika" sort="Yamaguchi, Mika" uniqKey="Yamaguchi M" first="Mika" last="Yamaguchi">Mika Yamaguchi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Fukushi, Kiyoshi" sort="Fukushi, Kiyoshi" uniqKey="Fukushi K" first="Kiyoshi" last="Fukushi">Kiyoshi Fukushi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Nagatsuka, Shin Ichiro" sort="Nagatsuka, Shin Ichiro" uniqKey="Nagatsuka S" first="Shin-Ichiro" last="Nagatsuka">Shin-Ichiro Nagatsuka</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>ADME/TOX Research Institute, Daiichi Pure Chemicals Co., Tokai-mura</s1>
<s2>Naka-gun, Ibaraki 319-1182</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Iyo, Masaomi" sort="Iyo, Masaomi" uniqKey="Iyo M" first="Masaomi" last="Iyo">Masaomi Iyo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Asahina, Masato" sort="Asahina, Masato" uniqKey="Asahina M" first="Masato" last="Asahina">Masato Asahina</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Chiba University School of Medicine, Chuo-ku</s1>
<s2>Chiba-shi, Chiba 260-8670</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hattori, Takamichi" sort="Hattori, Takamichi" uniqKey="Hattori T" first="Takamichi" last="Hattori">Takamichi Hattori</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Chiba University School of Medicine, Chuo-ku</s1>
<s2>Chiba-shi, Chiba 260-8670</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Tanada, Shuji" sort="Tanada, Shuji" uniqKey="Tanada S" first="Shuji" last="Tanada">Shuji Tanada</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Irie, Toshiaki" sort="Irie, Toshiaki" uniqKey="Irie T" first="Toshiaki" last="Irie">Toshiaki Irie</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">03-0237949</idno>
<date when="2001">2001</date>
<idno type="stanalyst">PASCAL 03-0237949 INIST</idno>
<idno type="RBID">Pascal:03-0237949</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000B04</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000219</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy</title>
<author><name sortKey="Shinotoh, Hitoshi" sort="Shinotoh, Hitoshi" uniqKey="Shinotoh H" first="Hitoshi" last="Shinotoh">Hitoshi Shinotoh</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Namba, Hiroki" sort="Namba, Hiroki" uniqKey="Namba H" first="Hiroki" last="Namba">Hiroki Namba</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Yamaguchi, Mika" sort="Yamaguchi, Mika" uniqKey="Yamaguchi M" first="Mika" last="Yamaguchi">Mika Yamaguchi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Fukushi, Kiyoshi" sort="Fukushi, Kiyoshi" uniqKey="Fukushi K" first="Kiyoshi" last="Fukushi">Kiyoshi Fukushi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Nagatsuka, Shin Ichiro" sort="Nagatsuka, Shin Ichiro" uniqKey="Nagatsuka S" first="Shin-Ichiro" last="Nagatsuka">Shin-Ichiro Nagatsuka</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>ADME/TOX Research Institute, Daiichi Pure Chemicals Co., Tokai-mura</s1>
<s2>Naka-gun, Ibaraki 319-1182</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Iyo, Masaomi" sort="Iyo, Masaomi" uniqKey="Iyo M" first="Masaomi" last="Iyo">Masaomi Iyo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Asahina, Masato" sort="Asahina, Masato" uniqKey="Asahina M" first="Masato" last="Asahina">Masato Asahina</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Chiba University School of Medicine, Chuo-ku</s1>
<s2>Chiba-shi, Chiba 260-8670</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Hattori, Takamichi" sort="Hattori, Takamichi" uniqKey="Hattori T" first="Takamichi" last="Hattori">Takamichi Hattori</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Neurology, Chiba University School of Medicine, Chuo-ku</s1>
<s2>Chiba-shi, Chiba 260-8670</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Tanada, Shuji" sort="Tanada, Shuji" uniqKey="Tanada S" first="Shuji" last="Tanada">Shuji Tanada</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
<author><name sortKey="Irie, Toshiaki" sort="Irie, Toshiaki" uniqKey="Irie T" first="Toshiaki" last="Irie">Toshiaki Irie</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Japon</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
<imprint><date when="2001">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Advances in neurology</title>
<title level="j" type="abbreviated">Adv. neurol.</title>
<idno type="ISSN">0091-3952</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cartography</term>
<term>Cholinergic pathway</term>
<term>Human</term>
<term>In vivo</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Cartographie</term>
<term>Parkinson maladie</term>
<term>In vivo</term>
<term>Voie cholinergique</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Cartographie</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0091-3952</s0>
</fA01>
<fA02 i1="01"><s0>ADNRA3</s0>
</fA02>
<fA03 i2="1"><s0>Adv. neurol.</s0>
</fA03>
<fA05><s2>86</s2>
</fA05>
<fA08 i1="01" i2="1" l="ENG"><s1>In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Parkinson's disease</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>SHINOTOH (Hitoshi)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>NAMBA (Hiroki)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>YAMAGUCHI (Mika)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>FUKUSHI (Kiyoshi)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>NAGATSUKA (Shin-Ichiro)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>IYO (Masaomi)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>ASAHINA (Masato)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>HATTORI (Takamichi)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>TANADA (Shuji)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>IRIE (Toshiaki)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>CALNE (Donald)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>CALNE (Susan M.)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Division of Advanced Technology for Medical Imaging, National Institute of Radiological Sciences, Inage-ku</s1>
<s2>Chiba-shi, Chiba 263-8555</s2>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>9 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>ADME/TOX Research Institute, Daiichi Pure Chemicals Co., Tokai-mura</s1>
<s2>Naka-gun, Ibaraki 319-1182</s2>
<s3>JPN</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Neurology, Chiba University School of Medicine, Chuo-ku</s1>
<s2>Chiba-shi, Chiba 260-8670</s2>
<s3>JPN</s3>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver Hospital and Health Sciences Center, Purdy Pavillon</s1>
<s2>Vancouver, British Columbia</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
</fA15>
<fA18 i1="01" i2="1"><s1>World Federation of Neurology Research Committee on "Parkinsonism and Related Disorders"</s1>
<s3>INC</s3>
<s9>patr.</s9>
</fA18>
<fA18 i1="02" i2="1"><s1>Pacific Parkinsons Research Institute</s1>
<s3>CAN</s3>
<s9>patr.</s9>
</fA18>
<fA20><s1>249-255</s1>
</fA20>
<fA21><s1>2001</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>15741</s2>
<s5>354000109446770250</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2003 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>20 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>03-0237949</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Advances in neurology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Cartographie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Cartography</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Cartografía</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>04</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>In vivo</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>In vivo</s0>
<s5>07</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>In vivo</s0>
<s5>07</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Voie cholinergique</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Cholinergic pathway</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Vía colinérgica</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>146</s1>
</fN21>
<fN82><s1>PSI</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>Parkinson's Disease. International Congress</s1>
<s3>Vancouver CAN</s3>
<s4>1999-07-25</s4>
</fA30>
</pR>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000219 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000219 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:03-0237949
   |texte=   In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy

In vivo mapping of brain cholinergic function in Parkinson's disease and progressive supranuclear palsy

Source :

Descripteurs français

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri